Dry Eye Medication

RESTASIS™ is the first and only therapy for patients with Dry Eye Disease, whose tear production is presumed to be suppressed due to ocular inflammation.

Dry Eye Disease is a painful and irritating condition involving abnormalities and deficiencies in the tear film initiated by a variety of causes. Unlike artificial tears, RESTASIS™ is the first drug proven to effectively treat a cause of Dry Eye Disease rather than only temporarily alleviate symptoms. Call 1-866-RESTASIS for more information or visit their Allergan’s website www.allergan.com.